Market Update (NASDAQ:ALXN): Alexion Strengthens and Broadens Its Executive Leadership Team
September 17, 2014 at 07:30 AM EDT
[Business Wire] – Alexion Pharmaceuticals, Inc. today announced key measures to strengthen and broaden its executive leadership team in line with the Company’s expanding global mission Read more on this. Alexion Pharmaceuticals, . . . → Read More: Market Update (NASDAQ:ALXN): Alexion Strengthens and Broadens Its Executive Leadership Team Similar Articles: Company Update: Alexion Pharmaceuticals Inc (NASDAQ:ALXN) – Asfotase Alfa Granted Orphan Drug Designation in Japan Company Update: Merck & Co Inc (NYSE:MRK) – [video] Merck & Pfizer team up Stock Update (NASDAQ:ALXN): Alexion Initiates Multinational Registration Trial of Eculizumab for the Prevention of Delayed Graft Function (DGF) after Kidney Transplantation